West Pharmaceutical Services, Inc. Stock Sao Paulo

Equities

W2ST34

BRW2STBDR007

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 09:00:05 2024-06-27 am EDT 5-day change 1st Jan Change
50.35 BRL +0.30% Intraday chart for West Pharmaceutical Services, Inc. -.--% +2.65%
Sales 2024 * 3.01B 16.38B Sales 2025 * 3.28B 17.84B Capitalization 24.28B 132B
Net income 2024 * 570M 3.1B Net income 2025 * 668M 3.63B EV / Sales 2024 * 7.86 x
Net cash position 2024 * 617M 3.36B Net cash position 2025 * 1.02B 5.52B EV / Sales 2025 * 7.1 x
P/E ratio 2024 *
43.2 x
P/E ratio 2025 *
37.6 x
Employees 10,600
Yield 2024 *
0.28%
Yield 2025 *
0.33%
Free-Float 96.38%
More Fundamentals * Assessed data
Dynamic Chart
West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan MT
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value-Defensive Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000E Value Index CI
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing MT
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing MT
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
Jefferies Adjusts Price Target on West Pharmaceutical Services to $426 From $423 MT
More news
1 day+0.30%
1 month+3.60%
3 months-8.12%
6 months+2.23%
Current year+2.65%
More quotes
1 month
50.20
Extreme 50.2
51.90
Current year
48.05
Extreme 48.05
57.72
1 year
48.05
Extreme 48.05
57.72
3 years
30.70
Extreme 30.7
75.51
5 years
30.70
Extreme 30.7
75.51
10 years
30.70
Extreme 30.7
75.51
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 15-04-23
Director of Finance/CFO 55 18-06-20
Chief Tech/Sci/R&D Officer 52 18-02-25
Members of the board TitleAgeSince
Director/Board Member 66 11-01-31
Chief Executive Officer 55 15-04-23
Director/Board Member 63 16-09-11
More insiders
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
321.4 USD
Average target price
397.5 USD
Spread / Average Target
+23.70%
Consensus